Anzeige
Mehr »
Login
Mittwoch, 08.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
GameStop 2.0? ...alle Anzeichen für den nächsten großen Short Squeeze!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
455 Leser
Artikel bewerten:
(2)

The Law Office of D. Gill Sperlein: Elon Musk to pay critic Randeep Hothi to settle defamation lawsuit

Finanznachrichten News

SAN FRANCISCO, May 1, 2023 /PRNewswire/ -- Tesla CEO Elon Musk has settled a defamation case brought against him by Randeep Hothi, an outspoken critic and independent researcher who published original investigative work casting doubts on many of Tesla's claims about its technological capabilities, production capacity, and profitability. Hothi's longstanding criticism of Musk and his companies led to the dispute at the center of the case, in which Musk allegedly defamed Hothi in an e-mail to a reporter, accusing him of harassing and harming Tesla employees. Following lengthy and hard-fought litigation, in March 2023, Musk asked Hothi to settle the case. In a statement released today, Hothi announced that he accepted Musk's settlement offer.

Randeep Hothi

"I brought this case to defend my work, clear my name, and send a message," said Hothi. "I believe I've accomplished that, thanks in no small part to Musk, whose own behavior over the last year has highlighted the need to scrutinize his every word and deed. This case was about taking a stand, not seeking fame or money. I feel vindicated."

Hothi's lawsuit followed a multi-year campaign by Musk attacking Hothi for his outspoken criticisms of Tesla. In April 2019, Tesla sought a restraining order against Hothi, alleging that Hothi struck an employee with his car in a Tesla factory parking lot. Hothi vehemently denied the accusation. When Hothi and his legal team successfully obtained a court order requiring Tesla to hand over video evidence of the alleged encounter, Tesla abruptly dropped its lawsuit in July 2019. Yet the following month, Musk e-mailed a reporter accusing Hothi of "actively harassing" and "almost kill[ing]" Tesla employees. That remark was later published and amplified to hundreds of thousands of people on Twitter. Musk's accusations prompted an outpouring of public support for Hothi, including from whistleblowers, researchers, journalists, and critics.

D. Gill Sperlein, one of Hothi's lawyers, said: "Last year, Musk famously promised that he would never 'settle an unjust case.' Yet, he has asked Mr. Hothi to accommodate him. We welcome Musk's belated acknowledgment that this case was just." Sperlein, who has represented Hothi since 2019, added: "Freedom of speech is undermined when the rich and powerful improperly act to silence and intimidate their critics."

In August 2020, represented by Sperlein, Hothi filed a defamation lawsuit against Musk based on his remarks. Musk attempted to dispose of the case by arguing that his accusations were protected speech, and hence should be dismissed under California's anti-SLAPP law. In January 2021, the trial court rejected Musk's arguments, holding that Hothi "has demonstrated the probability that he can succeed on the merits of his claim" because Musk's remarks were tantamount to an accusation of crime, and thus legally constituted defamation per se. In California, a plaintiff alleging defamation per se does not need to prove damages because harm is assumed, and juries are instructed they may award any sum they believe is reasonable, but no less than one dollar. Musk appealed, but a California Court of Appeal panel unanimously affirmed the trial court's refusal to dismiss the case in December 2021. Thereafter, the parties commenced discovery. Hothi accepted Musk's settlement offer on April 30, and is expected to request dismissal of the case on May 1, pursuant to the terms of the settlement agreement.The case is Hothi v. Musk, No. RG20069852 (Alameda Super. Ct.).

For more information on the case, contact:

D. Gill Sperlein, (415) 378-2625, gill@sperleinlaw.com

Photo - https://mma.prnewswire.com/media/2066935/Randeep_Hothi.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/the-law-office-of-d-gill-sperlein-elon-musk-to-pay-critic-randeep-hothi-to-settle-defamation-lawsuit-301812223.html

© 2023 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.